![Manuel Fernandez Bibiloni](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manuel Fernandez Bibiloni
Chief Executive Officer at Biomakers Molecular Pathology & Research
Profile
Manuel Fernandez Bibiloni has a current job as Co-Chief Executive Officer at Biomakers Molecular Pathology & Research.
Manuel Fernandez Bibiloni active positions
Companies | Position | Start |
---|---|---|
Biomakers Molecular Pathology & Research
![]() Biomakers Molecular Pathology & Research Pharmaceuticals: MajorHealth Technology Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation. | Chief Executive Officer | 2018-09-30 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Biomakers Molecular Pathology & Research
![]() Biomakers Molecular Pathology & Research Pharmaceuticals: MajorHealth Technology Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Manuel Fernandez Bibiloni